^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EFNB2 negative

i
Other names: EFNB2, Ephrin B2, HTK Ligand, Ephrin-B2, LERK5, HTKL, Eph-Related Receptor Tyrosine Kinase Ligand 5, Ligand Of Eph-Related Kinase 5, EPLG5, Htk-L, EPH-Related Receptor Tyrosine Kinase Ligand 5, MGC126226, MGC126227, MGC126228, LERK-5, EFNB2, HTK-L
Entrez ID:
Related biomarkers:
7ms
Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer. (PubMed, Indian J Otolaryngol Head Neck Surg)
Thus, EFNB2 has potential to be theranostic marker for CTX resistance. The online version contains supplementary material available at 10.1007/s12070-023-03739-9.
Journal
|
EGFR (Epidermal growth factor receptor) • EFNB2 (Ephrin B2) • IL1A (Interleukin 1, alpha) • SOCS3 (Suppressor Of Cytokine Signaling 3)
|
EGFR expression • EFNB2 negative • EFNB2 expression
|
Erbitux (cetuximab)
over2years
Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics. (PubMed, Ann Clin Lab Sci)
We constructed RS as a convincing prognostic index for ccRCC patients and found potential scientific target pathways.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-1 (Programmed cell death 1) • CD4 (CD4 Molecule) • EFNB2 (Ephrin B2)
|
PD-1 expression • EFNB2 negative